Bausch Health Americas, Inc.

This study is observing adults in Canada who are starting the psoriasis medication brodalumab as part of their regular care. Researchers will follow about 500 participants for one year to see how the treatment affects their quality of life, work productivity, and daily activities…

This early-stage study aimed to test whether inhaled Virazole (ribavirin) could help hospitalized adults with COVID-19 who were experiencing serious breathing problems. The trial planned to measure whether the treatment improved patients' breathing and overall condition. However,…

This study aims to understand the long-term safety of the psoriasis medication brodalumab compared to other treatments. It will follow 3,500 adults with moderate-to-severe psoriasis who are already starting a new treatment as part of their regular care. The main goal is to track …

This study is checking the safety and how a single dose of the drug brodalumab moves through the body in children and teenagers with severe plaque psoriasis. It involves a very small group of participants, aged 6 to under 18. The main goal is to gather initial information on how …

This study is testing whether a medication called rifaximin can delay the first serious brain complication in people with advanced liver disease (cirrhosis) who have controlled fluid buildup in their abdomen. About 466 participants will receive either the medication or a placebo …

This study is testing how well and how safely a newer version of the Fraxel laser works for improving skin appearance. It will involve about 50 adults with sun damage, discoloration, or wrinkles around the eyes. Participants will receive three laser treatments, and doctors will m…

This is a long-term safety study, not a treatment trial. Researchers are observing 8,000 children and teens with eczema who have already used Elidel cream. The goal is to track them for 10 years to see if using this common eczema medication is linked to any increased risk of deve…